Effects of pre and post-treatments with dipyridamole in gentamicin-induced acute nephrotoxicity in the rat
- 1 March 2017
- journal article
- research article
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 84, 35-44
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Higher Education
- Fundamental Research Grant Scheme (FRGS/2/2014/SKK01/AIMST/02/2)
This publication has 34 references indexed in Scilit:
- Fenofibrate and dipyridamole treatments in low-doses either alone or in combination blunted the development of nephropathy in diabetic ratsPharmacological Research, 2014
- Classical and pleiotropic actions of dipyridamole: Not enough light to illuminate the dark tunnel?Pharmacological Research, 2014
- Interleukin-10: An Anti-Inflammatory Marker To Target Atherosclerotic Lesions via PEGylated LiposomesMolecular Pharmaceutics, 2012
- Experimental Gentamicin Nephrotoxicity and Agents that Modify it: A Mini-Review of Recent ResearchBasic & Clinical Pharmacology & Toxicology, 2011
- Gentamicin-induced nephrotoxicity: Do we have a promising therapeutic approach to blunt it?Pharmacological Research, 2010
- The low dose combination of fenofibrate and rosiglitazone halts the progression of diabetes-induced experimental nephropathyEuropean Journal of Pharmacology, 2010
- Protective Effect of Quercetin against Gentamicin-Induced Nephrotoxicity in RatsBiological and Pharmaceutical Bulletin, 2009
- Acetylsalicylic acid + extended-release dipyridamole combination therapy for secondary stroke preventionClinical Therapeutics, 2008
- Conditions for "coronary steal" caused by coronary vasodilator in man.Japanese Heart Journal, 1982
- Conditions for vasodilator-induced coronary steal in experimental myocardial ischemia.Circulation, 1978